Man Zhu resumes & CV records
Resumes
Man Kwok Zhu, 431245 Chipman Ln, North Liberty, IA 52317
Man Zhu Phones & Addresses
North Liberty, IA
1188 Belmont Dr, Farmington, NY 14425 520-6035878
Cherry Hill, NJ
Philadelphia, PA
Williamstown, NJ
Flushing, NY
Schenectady, NY
New York, NY
Durham, NC
Latham, NY
Chandler, AZ
Social networks
Man Kwok Zhu
Linkedin
Mentions for Man Kwok Zhu
Publications & IP owners
Us Patents
Synthesis Of Ccr5 Receptor Antagonists
US Patent:
7728135, Jun 1, 2010
Filed:
Jan 5, 2006
Appl. No.:
11/326154
Inventors:
Xiongwei Shi - Edison NJ, US
Man Zhu - Clark NJ, US
William Leong - Westfield NJ, US
Vilas Dahanukar - Hyderabad, IN
Ilia A. Zavialov - Princeton NJ, US
Cecelia Proietti - Clark NJ, US
Shannon Zhao - Littleton MA, US
Hong-Chang Lee - Livingston NJ, US
Yi Liu - Clark NJ, US
Hoa N. Nguyen - Dayton NJ, US
Wenxue Wu - Princeton Junction NJ, US
Bosco D'Sa - Edison NJ, US
Feng Liang - Monmouth Junction NJ, US
Loc Thanh Tran - Parsippany NJ, US
Man Zhu - Clark NJ, US
William Leong - Westfield NJ, US
Vilas Dahanukar - Hyderabad, IN
Ilia A. Zavialov - Princeton NJ, US
Cecelia Proietti - Clark NJ, US
Shannon Zhao - Littleton MA, US
Hong-Chang Lee - Livingston NJ, US
Yi Liu - Clark NJ, US
Hoa N. Nguyen - Dayton NJ, US
Wenxue Wu - Princeton Junction NJ, US
Bosco D'Sa - Edison NJ, US
Feng Liang - Monmouth Junction NJ, US
Loc Thanh Tran - Parsippany NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D 401/14
C07D 403/12
A61K 31/506
A61K 31/18
C07D 403/12
A61K 31/506
A61K 31/18
US Classification:
544295, 544364, 544335
Abstract:
The present invention is directed to the synthesis of 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine], and intermediates therefor from readily available starting materials by a novel route.
Xinafoate Salt Of A Substituted 5-Oxazol-2-Yl-Quinoline Compound
US Patent:
7919505, Apr 5, 2011
Filed:
Jul 10, 2007
Appl. No.:
11/775383
Inventors:
Pauline C. Ting - New Providence NJ, US
Joe F. Lee - Brooklyn NY, US
Kung-I Feng - Basking Ridge NJ, US
Michael R. Reeder - Skillman NJ, US
Scott T. Trzaska - Raritan NJ, US
Man Zhu - Clark NJ, US
Chen Mao - New Providence NJ, US
Dimitar L. Filipov - Elizabeth NJ, US
Dimitrios N. Zarkadas - Fanwood NJ, US
Joe F. Lee - Brooklyn NY, US
Kung-I Feng - Basking Ridge NJ, US
Michael R. Reeder - Skillman NJ, US
Scott T. Trzaska - Raritan NJ, US
Man Zhu - Clark NJ, US
Chen Mao - New Providence NJ, US
Dimitar L. Filipov - Elizabeth NJ, US
Dimitrios N. Zarkadas - Fanwood NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D 215/38
A61K 31/04
A61K 31/04
US Classification:
514312, 546159, 546163
Abstract:
The present invention relates to the compound of the formula.
Synthesis Of Piperidine And Piperazine Compounds As Ccr5 Antagonists
US Patent:
2004002, Feb 5, 2004
Filed:
Mar 27, 2003
Appl. No.:
10/401070
Inventors:
William Leong - Westfield NJ, US
Minzhang Chen - Plainsboro NJ, US
Bosco D'sa - Edison NJ, US
Man Zhu - Clark NJ, US
Tong Xiao - Edison NJ, US
Xiongwei Shi - Edison NJ, US
Suhan Tang - Plainsboro NJ, US
Dinesh Gala - East Brunswick NJ, US
Andrew Goodman - Annandale NJ, US
Christopher Nielsen - Westfield NJ, US
Gary Lee - Belmont CA, US
Juan Gamboa - New York NY, US
Andrew Jones - Lexington MA, US
Minzhang Chen - Plainsboro NJ, US
Bosco D'sa - Edison NJ, US
Man Zhu - Clark NJ, US
Tong Xiao - Edison NJ, US
Xiongwei Shi - Edison NJ, US
Suhan Tang - Plainsboro NJ, US
Dinesh Gala - East Brunswick NJ, US
Andrew Goodman - Annandale NJ, US
Christopher Nielsen - Westfield NJ, US
Gary Lee - Belmont CA, US
Juan Gamboa - New York NY, US
Andrew Jones - Lexington MA, US
Assignee:
Schering Corporation
International Classification:
C 07D 4 1/14
US Classification:
546/187000
Abstract:
In its several embodiments, this invention discloses novel processes to prepare the compounds of formula II and formula IV:
Synthesis Of Piperidine And Piperazine Compounds As Ccr5 Antagonists
US Patent:
2005018, Aug 25, 2005
Filed:
Mar 24, 2005
Appl. No.:
11/088585
Inventors:
William Leong - Westfield NJ, US
Minzhang Chen - Plainsboro NJ, US
Bosco D'sa - Edison NJ, US
Man Zhu - Clark NJ, US
Tong Xiao - Edison NJ, US
Xiongwei Shi - Edison NJ, US
Suhan Tang - Edison NJ, US
Dinesh Gala - East Brunswick NJ, US
Andrew Goodman - Annandale NJ, US
Christopher Nielsen - Westfield NJ, US
Gary Lee - Belmont CA, US
Juan Gamboa - New York NY, US
Andrew Jones - Lexington MA, US
Minzhang Chen - Plainsboro NJ, US
Bosco D'sa - Edison NJ, US
Man Zhu - Clark NJ, US
Tong Xiao - Edison NJ, US
Xiongwei Shi - Edison NJ, US
Suhan Tang - Edison NJ, US
Dinesh Gala - East Brunswick NJ, US
Andrew Goodman - Annandale NJ, US
Christopher Nielsen - Westfield NJ, US
Gary Lee - Belmont CA, US
Juan Gamboa - New York NY, US
Andrew Jones - Lexington MA, US
International Classification:
C07D041/14
A61K031/4545
A61K031/4545
US Classification:
514316000, 546187000
Abstract:
In its several embodiments, this invention discloses novel processes to prepare the compounds of formula II and formula IV:
Synthesis Of Ccr5 Receptor Antagonists
US Patent:
2010003, Feb 11, 2010
Filed:
Oct 16, 2009
Appl. No.:
12/580855
Inventors:
Xiongwei Shi - Edison NJ, US
Man Zhu - Clark NJ, US
William Leong - Westfield NJ, US
Vilas Dahanukar - Hyderabad, IN
Ilia A. Zavialov - Princeton NJ, US
Cecilia Proietti - Westfield NJ, US
Shannon Zhao - Littleton MA, US
Hong-Chang Lee - Livingston NJ, US
Yi Liu - Iselin NJ, US
Hoa N. Nguyen - Dayton NJ, US
Wenxue Wu - Princeton Junction NJ, US
Bosco D'Sa - Edison NJ, US
Feng Liang - Monmouth Junction NJ, US
Loc Thanh Tran - Piscataway NJ, US
Man Zhu - Clark NJ, US
William Leong - Westfield NJ, US
Vilas Dahanukar - Hyderabad, IN
Ilia A. Zavialov - Princeton NJ, US
Cecilia Proietti - Westfield NJ, US
Shannon Zhao - Littleton MA, US
Hong-Chang Lee - Livingston NJ, US
Yi Liu - Iselin NJ, US
Hoa N. Nguyen - Dayton NJ, US
Wenxue Wu - Princeton Junction NJ, US
Bosco D'Sa - Edison NJ, US
Feng Liang - Monmouth Junction NJ, US
Loc Thanh Tran - Piscataway NJ, US
International Classification:
C07D 401/06
C07D 211/30
C07D 211/30
US Classification:
544360, 546248
Abstract:
The present invention is directed to the synthesis of 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl--piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine], and intermediates therefor from readily available starting materials by a novel route.
Hydrogen Chloride Salt Of A Substituted 5-Oxazol-2-Yl-Quinoline Compound And A Process For The Production Thereof
US Patent:
2011000, Jan 6, 2011
Filed:
Jul 3, 2008
Appl. No.:
12/668191
Inventors:
Man Zhu - Clark NJ, US
Assignee:
SCHERING CORPORATION - Kenilworth NJ
International Classification:
A61K 31/56
C07D 413/14
A61K 31/4709
A61P 11/00
A61P 11/06
C07D 413/14
A61K 31/4709
A61P 11/00
A61P 11/06
US Classification:
514171, 546167, 514314
Abstract:
The present invention relates to the compound of the Formula I:and to methods of treating upper and lower obstructive airway diseases using said compound, to formulations comprising it, and to a particular crystalline form and processes of synthesis of the crystalline form.IM=105109
Process And Intermediates For The Synthesis Of Heterocyclic Substituted Piperazines With Cxcr3 Antagonist Activity
US Patent:
2011012, May 26, 2011
Filed:
Dec 16, 2008
Appl. No.:
12/809101
Inventors:
Frank Xing Chen - Plainsboro NJ, US
Timothy D. Cutarelli - Clinton NJ, US
Xiayong Fu - Edison NJ, US
Xian Liang - Monmouth Junction NJ, US
Timothy L. McAllister - , US
Robert K. Orr - Cranford NJ, US
Jianguo Yin - Plainsboro NJ, US
Kelvin H. Yong - Lyndhurst NJ, US
Man Zhu - Clark NJ, US
Timothy D. Cutarelli - Clinton NJ, US
Xiayong Fu - Edison NJ, US
Xian Liang - Monmouth Junction NJ, US
Timothy L. McAllister - , US
Robert K. Orr - Cranford NJ, US
Jianguo Yin - Plainsboro NJ, US
Kelvin H. Yong - Lyndhurst NJ, US
Man Zhu - Clark NJ, US
Assignee:
Schering Corporation - Kenilworth NJ
International Classification:
C07D 413/14
C07D 401/14
C07D 403/04
C07D 241/04
C07D 211/44
C07D 401/14
C07D 403/04
C07D 241/04
C07D 211/44
US Classification:
544357, 544389, 546220
Abstract:
The present invention relates to novel processes for the preparation of the compound of the Formula A45:or a physiologically acceptable salt, solvate or prodrug thereof, which has utility, for example, as a pharmaceutically active compound with CXCR3 antagonist activity, and to novel intermediates useful in the synthesis thereof.
Novel Tetragalnac Containing Conjugates And Methods For Delivery Of Oligonucleotides
US Patent:
2017023, Aug 17, 2017
Filed:
Nov 29, 2016
Appl. No.:
15/363490
Inventors:
- Cambridge MA, US
Steven COLLETTI - West Point PA, US
Vadim DUDKIN - West Point PA, US
Norihiro IKEMOTO - Rahway NJ, US
Hongbiao LIAO - Rahway NJ, US
Craig PARISH - Rahway NJ, US
Tao PEI - Rahway NJ, US
Anthony SHAW - West Point PA, US
Quang TRUONG - Rahway NJ, US
Lijun WANG - Whitehouse Station NJ, US
Yu YUAN - Orlando FL, US
Man ZHU - Rahway NJ, US
Steven COLLETTI - West Point PA, US
Vadim DUDKIN - West Point PA, US
Norihiro IKEMOTO - Rahway NJ, US
Hongbiao LIAO - Rahway NJ, US
Craig PARISH - Rahway NJ, US
Tao PEI - Rahway NJ, US
Anthony SHAW - West Point PA, US
Quang TRUONG - Rahway NJ, US
Lijun WANG - Whitehouse Station NJ, US
Yu YUAN - Orlando FL, US
Man ZHU - Rahway NJ, US
International Classification:
C12N 15/113
Abstract:
Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.
Public records
Vehicle Records
Man Zhu
Address:
1188 Belmont Dr, Farmington, NY 14425
VIN:
WBAVC73527KP32462
Make:
BMW
Model:
3 SERIES
Year:
2007
Possible Relatives
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.